AdamBisagaMD

PubMed

• Commentary on Foot et al.: Clinical considerations in addressing comorbid stimulant use in opioid use disorder.
  Miranda Greiner, Adam Bisaga, Shulman, M.> ;Addiction. 2024 Jan 1
• "Because of this rotation, this is what I want to do": Implementation and evaluation of a telehealth opioid use disorder clinical placement for nurse practitioner stud...
  Rachel French, Erica Lyons, Allison Schachter, June A Treston, Ami Marshall, Jennie Lattimer, Adam Bisaga, Emily Behar, Shoshana V Aronowitz> ;Journal of the American Association of Nurse Practitioners. 2023 Dec 1
• 1 citations
  Mixed amphetamine salts-extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trial.
  Kenneth M Carpenter, C Jean Choi, Cale Basaraba, Martina Pavlicova, Daniel J Brooks, Christina A Brezing, Adam Bisaga, Edward V Nunes, John J Mariani, Frances R Levin> ;Experimental and Clinical Psychopharmacology. 2024 Feb 1
• 1 citations
  Urine Drug Screening in a Telehealth Setting for the Treatment of Opioid Use Disorder.
  Arthur Robin Williams, Christopher Rowe, Ryan Gallagher, Shoshana V Aronowitz, Jon Diamond-Reivich, Adam Bisaga> ;JAMA Health Forum. 2023 Jul 7
• Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention...
  Vitor Tardelli, Adam Bisaga, Frances R Levin, Thiago M Fidalgo, Richard A Grucza, Xu, K. Y., Xu, K. Y., Kevin Y Xu> ;BMJ Mental Health. 2023 Jul 1
• Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study.
  Greiner, M., Shulman, M., Opara, O., Potter, K., Voronca, D., Tafessu, H., Hefner, K., Hamilton, A., Scheele, C., Ho, R., Dresser, L., Jelstrom, E., Fishman, M., Ghitz...> ;Contemporary Clinical Trials. 2023 May 1
• 3 citations
  Telehealth for opioid use disorder: retention as a function of demographics and rurality.
  Arthur Robin Williams, Shoshana V Aronowitz, Christopher Rowe, Ryan Gallagher, Emily Behar, Adam Bisaga> ;The American Journal of Drug and Alcohol Abuse. 2023 Mar 4
• 3 citations
  Prescription psychostimulants for cocaine use disorder: A review from molecular basis to clinical approach.
  Vitor S Tardelli, Lais F Berro, Gilberto Gerra, Leonardo Tadonio, Adam Bisaga, Thiago M Fidalgo> ;Addiction Biology. 2023 Jan 1
• 2 citations
  Evidence-based Treatment for Stimulant Use Disorder: Time to Hit the Community.
  Vitor S Tardelli, Adam Bisaga, Leonardo Tadonio, Gilberto Gerra, Thiago M Fidalgo> ;Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 2023 May 1
• 4 citations
  A Virtual-First Telehealth Treatment Model for Opioid Use Disorder.
  Arthur Robin Williams, Shoshana Aronowitz, Ryan Gallagher, Emily Behar, Zack Gray, Adam Bisaga> ;Journal of General Internal Medicine. 2023 Feb 1
• 4 citations
  Continuing Increase in Stimulant Dependence - Time to Implement Medical Treatment.
  Adam Bisaga, Vitor S Tardelli, Gilberto Gerra, Anja Busse, Giovanna Campello, Wataru Kashino, Elizabeth Saenz, Thiago M Fidalgo> ;Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 2022 Jul 1
• 2 citations
  Shapes of subcortical structures in adolescents with and without familial history of substance use disorder.
  Zhishun Wang, Diana V Rodriguez-Moreno, Yael M Cycowicz, Lawrence V Amsel, Keely Cheslack-Postava, Xiaofu He, Megan Ryan, Lupo Geronazzo-Alman, George J Musa, Adam Bis...> ;Human Brain Mapping. 2022 Jun 15
• 1 citations
  Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials.
  Mei-Chen Hu, Maria A Sullivan, Sarah C Akerman, James Fratantonio, Vincent Barbieri, Edward V Nunes, Adam Bisaga, Shulman, M.> ;Drug and Alcohol Dependence. 2022 Apr 1
• Initiating Long-acting Injectable Naltrexone: Procedure for a Second Attempt After a First Attempt Fails.
  Mei Chen Hu, Edward V Nunes, Adam Bisaga, Shulman, M.> ;Journal of Addiction Medicine. 2022 Feb 14
• 2 citations
  White matter integrity and functional connectivity in adolescents with a parental history of substance use disorder.
  Xiaofu He, Diana V Rodriguez-Moreno, Yael M Cycowicz, Keely Cheslack-Postava, Huilan Tang, Zhishun Wang, Lawrence V Amsel, Megan Ryan, Lupo Geronazzo-Alman, George J M...> ;Neuroimage. Reports. 2021 Sep 1
• 3 citations
  Google Trends Data: A Potential New Tool for Monitoring the Opioid Crisis.
  Abhishek Ghosh, Adam Bisaga, Simranjit Kaur, Tathagata Mahintamani> ;European Addiction Research. 2021 Jul 15
• 6 citations
  Pilot randomized placebo-controlled clinical trial of high-dose gabapentin for alcohol use disorder.
  John J. Mariani, Martina Pavlicova, Cale Basaraba, Agnieszka Mamczur-Fuller, Daniel J. Brooks, Adam Bisaga, Kenneth M. Carpenter, Edward V. Nunes, Frances R. Levin> ;Alcoholism, Clinical and Experimental Research. 2021 Aug 1
• 1 citations
  Discovering Non-Invasive Biomarkers Predictive of Opioid Use Disorder Treatment Response.
  Amir Levine, Kelly Clemenza, Shira H Weiss, Adam Bisaga, Erez Eitan, Maria Carla Gerra, Claudia Donnini, Gilberto Gerra, Benjamin A. Garcia> ;Cns Spectrums. 2021 Apr 1
• 4 citations
  Delay discounting and neurocognitive correlates among inner city adolescents with and without family history of substance use disorder.
  Diana V. Rodriguez-Moreno, Yael M. Cycowicz, Bernd Figner, Zhishun Wang, Xiaofu He, Lupo Geronazzo-Alman, Xiaoxiao Sun, Keely Cheslack-Postava, Adam Bisaga, Christina ...> ;Developmental Cognitive Neuroscience. 2021 Mar 11
• 3 citations
  Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial.
  Frances R. Levin, John J. Mariani, Martina Pavlicova, C. Jean Choi, Cale Basaraba, Amy L. Mahony, Daniel J. Brooks, Nasir H. Naqvi, Adam Bisaga> ;Drug and Alcohol Dependence. 2021 Feb 1
• 5 citations
  The utility of a formative one-station objective structured clinical examination for Substance use disorders in a dental curriculum.
  Folarin Odusola, Jennifer L. Smith, Eva Turrigiano, John T. Grbic, James B. Fine, Mei-Chen Hu, Edward V. Nunes, Adam Bisaga, Frances R. Levin> ;European Journal of Dental Education. 2021 Jan 20
• 10 citations
  Quetiapine treatment for cannabis use disorder
  John J. Mariani, Martina Pavlicova, C. Jean Choi, Cale Basaraba, Kenneth M. Carpenter, Amy L. Mahony, Daniel J. Brooks, Adam Bisaga, Nasir H. Naqvi, Edward V. Nunes, F...> ;Drug and Alcohol Dependence. 2021 Jan 1
• 3 citations
  The acute and repeated effects of cigarette smoking and smoking-related cues on impulsivity.
  Suky Martinez, Jermaine D. Jones, Nehal P. Vadhan, Laura Brandt, Sandra D. Comer, Adam Bisaga> ;Drug and Alcohol Review. 2020 Nov 2
• Reply to Kunoe (2020) and Ghosh & Singh (2020) regarding Nunes et al. (2020): Opioid use and dropout from extended-release naltrexone in a controlled trial: implicatio...
  Edward V. Nunes, Adam Bisaga, Evgeny Krupitsky, Narinder Nangia, Bernard L. Silverman, Sarah C. Akerman, Maria A. Sullivan> ;Addiction. 2020 Jul 16
• 8 citations
  Medical Student Attitudes Toward Substance Use Disorders Before and After a Skills-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) Curriculum.
  Jeremy D. Kidd, Jennifer L. Smith, Mei-Chen Hu, Eva Turrigiano, Adam Bisaga, Edward V. Nunes, Frances R. Levin> ;Advances in Medical Education and Practice. 2020 Jun 30
• Join now to see all

Journal Articles

• American Psychiatric Association Publishing  
  Adam Bisaga, Frances R Levin, John J Mariani, Maria A Sullivan, Edward V Nunes, National Institutes of Health
• The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone  
  Bisaga A, Sullivan MA, Glass A, Mishlen K, Pavlicova M, Haney M, Raby WN, Levin FR, Carpenter KM, Mariani JJ, Nunes EV, Drug Alcohol Depend, 1/1/2015
• Baseline Characteristics of Patients Predicting Suitability for Rapid Naltrexone Induction  
  Mogali S, Khan NA, Drill ES, Pavlicova M, Sullivan MA, Nunes EV, Bisaga A, Am J Addictions, 1/1/2014
• Conditioned rewarding effects of morphine and methadone in mice pre-exposed to cocaine  
  Holuj M, Bisaga A, Popik P, Pharmacological Reports, 1/1/2013
• Opioid Detoxification and Naltrexone Induction Strategies: Recommendations for Clinical Practice  
  Sigmon, S.C., Bisaga, A., Nunes, E.V., O'Connor, P.G., Kosten, T., Woody, G., Am. J. Drug & Alc. Abuse, 1/1/2012
• Comparison of substance use milestones in cannabis- and cocaine-dependent patients  
  Horey JT. Mariani, JJ, Cheng WY, Bisaga A, Sullivan MA, Nunes EV, Levin. FR, J. Addict. Dis, 1/1/2012
• Extended-Release Mixed Amphetamine Salts and Topiramate for Cocaine Dependence: A Randomized Controlled Trial  
  Mariani JJ, Pavlicova M, Bisaga A, Nunes EV, Brooks DJ, Levin FR, Biol Psych, 1/1/2012
• A comparison of independent depression and substance-induced depression in cannabis, cocaine, and opioid dependent treatment seekers  
  Dakwar E, Nunes EV, Bisaga A, Carpenter K, Mariani J, Sullivan M, Raby W, Levin FR, Am J Drug Alcohol Abuse, 1/1/2011
• Long acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: A quasi-experiment  
  Brooks A, Sullivan MA, Comer SD, Bisaga A, Carpenter KM, Raby, Yu E, O’Brien, and Nunes EV, J. Clin. Psych, 1/1/2010
• Sex differences and hormonal influences on response to mechanical pressure pain in humans  
  Kowalczyk WJ, Sullivan MA, Evans SE, Bisaga A, Vosburg SK, Comer SD, J Pain., 1/1/2010
• Evaluation of potential sex differences in the subjective and analgesic effects of morphine in normal, healthy volunteers  
  Comer SD, Cooper Z, Kowalczyk W, Sullivan M, Evans S, Bisaga A, Vosburg S, Psychopharmacology, 1/1/2010
• A placebo controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period  
  Bisaga A, Aharonovich E, Cheng W, Levin FR, Mariani JM, Raby WN, Nunes EV, Drug Alcohol Depend, 1/1/2010
• Acute Interaction of Baclofen in Combination with Alcohol in Heavy Drinkers  
  Evans SM, Bisaga A, Alcohol Clin. Exp. Res., 1/1/2009
• Betting on Change: Modeling transitional probabilities to guide therapy development for opioid dependence  
  Carpenter K, Jiang HP, Sullivan MA, Bisaga A, Comer SD, Raby WN, Brooks AC, Nunes EV, Psychol. Addict. Behaviors, 1/1/2009
• Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence  
  Raby WN, Carpenter KM, Rothenberg JL, Brooks AC, Jiang H, Bisaga A, Comer SD and Nunes EV, Am. J. Addictions, 1/1/2009
• Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial  
  Levin FR, Mariani JJ, Secora A, Brooks D, Cheng WY, Bisaga A, Nunes E, Aharonovich E, Raby W, Hennessy G, J. Dual. Diagn., 1/1/2009
• Effects of major depression and attention deficit/hyperactivity disorder on the outcome of treatment for cocaine-dependence  
  Levin FR, Bisaga A, Raby WN, Aharonovich E, Rubin E, Mariani J, Brooks D, Garawi F, Nunes EV, J Substance Abuse Treat, 1/1/2008
• Dextromethorphan and quinidine combination for heroin detoxification  
  Akerele E, Bisaga A, Nunes EV, Garawi F, Sullivan MA, Comer SD, Kleber HD, Am. J. Addictions, 1/1/2008
• Antisocial behavioral syndromes in cocaine and cannabis dependence  
  Mariani J, Horey J, Bisaga A, Aharonovich E, Raby W, Nunes E, Levin FR, Am. J. Drug Alcohol Abuse, 1/1/2008
• A novel procedure for assessing the effects of drugs on satiation in baboons: effects of memantine and dexfenfluramine  
  Foltin R, Danysz W, Bisaga A, Psychopharmacology, 1/1/2008
• Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder  
  Bisaga A, Daysz W, Foltin R, Eur. Neuropsychopharmacology, 1/1/2008
• The Clinical Relations between Cognition, Commitment Language and Behavioral Change in Cocaine Dependent Patients  
  Aharonovich E, Hasin D, Bisaga A, Nunes AV, Amrhein P, Psychol. Addict. Behaviors, 1/1/2008
• Early abstinence in cocaine dependence: Influence of comorbid major depression  
  Rubin E., Aharonovich E., Bisaga A., Levin F.R., Raby W.N., Nunes E.V., Am J Addictions, 1/1/2007
• A randomized placebo controlled trial of gabapentin for cocaine dependence  
  Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, Nunes EV, Drug Alcohol Depend, 1/1/2006
• Cognitive Deficits as Predictors of Treatment Retention in Cocaine Dependent Patients  
  Aharonovich E, Hasin D, Brooks A, Xinhua L, Bisaga A, Nunes EV, Drug Alcohol Depend, 1/1/2006
• Join now to see all